Actively Recruiting
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
Led by Affiliated Hospital of Nantong University · Updated on 2024-12-04
64
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.
CONDITIONS
Official Title
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing selective laparoscopic hysterectomy
- Receiving general anesthesia
- ASA classification I to III
- Aged between 18 and 65 years
You will not qualify if you...
- Allergy to oxycodone or any study drugs
- Use of opioid medications before surgery
- History of opioid abuse
- Liver or kidney dysfunction
- Heart or lung problems
- Lack of full legal capacity or refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Affiliated hospital of Nantong University
Nantong, Jiangsu, China, 226001
Actively Recruiting
Research Team
S
Siyuan Liu, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here